Return on Invested Capital (ROIC): -163.98%

Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of -163.98% is 77% above its 1-year average of -724.77%, near the high end of its 1-year range (-1285.56%–-163.98%).

As of the fiscal period ended Tuesday, June 30, 2026.

LABT Return on Invested Capital (ROIC) Metrics

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Lakewood-Amedex Biotherapeutics, Inc. (LABT)?

The return on invested capital (ROIC) for LABT stock is -163.98%.

Is Lakewood-Amedex Biotherapeutics, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of -163.98% is 77% above its 1-year average of -724.77%, near the high end of its 1-year range (-1285.56%–-163.98%).

Related Metrics